Pharmaceutical and health-related R&D expenditure by OECD region 2016

This statistic shows the pharmaceutical and health-related research and development expenditure by OECD region and type in 2016. In that year, R&D expenditure in the U.S. pharmaceutical sector which came from business enterprises (BERD) stood at almost 65 billion U.S. dollars while health-related R&D spending from governmental budgets (GBARD) stood at some 36 billion dollars.